News and Events

On the heels of the FDA approval of the new software updates for the Freedom Driver, SynCardia was out in force at the 2023 Annual Conference of the American Society of Artificial Internal Organs (ASAIO)

A preliminary proxy statement has been filed with the Securities and Exchange Commission by Altitude Acquisition Corp. for its proposed merger with Picard Medical, Inc and SynCardia Systems LLC.

As a platinum sponsor of the HeartHackathon, Tucson, Arizona-based SynCardia is demonstrating its commitment to education, innovation, and to advancing the field of artificial heart technologies.

SynCardia Systems, LLC., a Picard Medical Company, today announced that the U.S. Food and Drug Administration (FDA) has approved an update of the SynCardia TAH-t label with real world data further confirming the safety and performance of the Companion 2 Driver.

Celebrating Randy’s incredible 10-year anniversary since receiving a Total Artificial Heart! Despite facing immense challenges, Randy has shown us what it means to live life to the fullest and embrace every opportunity with unwavering determination.

We are excited about the announcement that Patrick NJ Schnegelsberg is the new Chief Executive Officer of SynCardia Systems, LLC the parent company of Picard Medical, Inc. A global leader in mechanical heart replacement technology.